Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

MLA

Tatsuo Oyake, et al. “Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC Trial): A Randomized Controlled Trial from Japan FN Study Group.” Blood, vol. 132, Nov. 2018, p. 816. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........36f33797c0e159df33abc4848cafde51&authtype=sso&custid=ns315887.

APA

Tatsuo Oyake, Kazuo Tamura, Emiko Sakaida, Shin-ichiro Fujiwara, Jun Yamanouchi, Shingen Nakamura, Akinao Okamoto, Hiroki Yamaguchi, Yoshinobu Kanda, Shun-ichi Kimura, Masaki Iino, Yoshio Saburi, Hiroyuki Fujita, Itaru Matsumura, Yasushi Takamatsu, Moritaka Gotoh, Takahiro Fukuda, Junji Suzumiya, & Souichi Shiratori. (2018). Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group. Blood, 132, 816.

Chicago

Tatsuo Oyake, Kazuo Tamura, Emiko Sakaida, Shin-ichiro Fujiwara, Jun Yamanouchi, Shingen Nakamura, Akinao Okamoto, et al. 2018. “Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC Trial): A Randomized Controlled Trial from Japan FN Study Group.” Blood 132 (November): 816. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........36f33797c0e159df33abc4848cafde51&authtype=sso&custid=ns315887.